← Back to latest
Landmark pancreatic cancer drug shows potential against lung cancer too
Results bolster hopes that the drug daraxonrasib could prove effective against a variety of tumours.
Just one week after the landmark US approval of a game-changing drug for advanced pancreatic cancer, the same therapy is showing promise against the world’s biggest cancer killer: lung cancer.
In a small clinical trial of the drug daraxonrasib (Rason... [2635 chars]
News providers only return a preview of the article body. Continue reading the full story at the original source.
Nature →
